Innovation Medical(SZ:002173) Zhi Tong Cai Jing·2026-01-12 14:05Core Viewpoint - The stock of Innovation Medical (002173.SZ) experienced a significant price fluctuation, with a cumulative increase of over 20% in closing prices over three consecutive trading days in January 2026, indicating abnormal trading activity [1] Group 1: Company Overview - Innovation Medical's subsidiary, Bole Brain Machine (Hangzhou) Technology Co., Ltd., was established in early 2021 and was included in the consolidated financial statements in August 2025 [1] - The primary products of Bole Brain Machine are designed for rehabilitation training of patients with cerebrovascular diseases, particularly focusing on stroke and paralysis [1] Group 2: Product and Financial Performance - The product "Cyberlink AC5" was officially launched in October 2025, generating revenue of 114,000 yuan in that year [1] - The "Cyberlink AM5" has completed multi-center clinical trials but has not generated revenue in 2025 [1] - The operating losses for Bole Brain Machine were 6.60 million yuan in 2023 and 8.66 million yuan in 2024 [1]